99 related articles for article (PubMed ID: 24287382)
1. Identification through structure-based methods of a bacterial NAD(+)-dependent DNA ligase inhibitor that avoids known resistance mutations.
Murphy-Benenato K; Wang H; McGuire HM; Davis HE; Gao N; Prince DB; Jahic H; Stokes SS; Boriack-Sjodin PA
Bioorg Med Chem Lett; 2014 Jan; 24(1):360-6. PubMed ID: 24287382
[TBL] [Abstract][Full Text] [Related]
2. Identification and characterization of an inhibitor specific to bacterial NAD+-dependent DNA ligases.
Meier TI; Yan D; Peery RB; McAllister KA; Zook C; Peng SB; Zhao G
FEBS J; 2008 Nov; 275(21):5258-71. PubMed ID: 18795946
[TBL] [Abstract][Full Text] [Related]
3. Discovery of bacterial NAD+-dependent DNA ligase inhibitors: optimization of antibacterial activity.
Stokes SS; Huynh H; Gowravaram M; Albert R; Cavero-Tomas M; Chen B; Harang J; Loch JT; Lu M; Mullen GB; Zhao S; Liu CF; Mills SD
Bioorg Med Chem Lett; 2011 Aug; 21(15):4556-60. PubMed ID: 21719282
[TBL] [Abstract][Full Text] [Related]
4. The kinetic mechanism of S. pneumoniae DNA ligase and inhibition by adenosine-based antibacterial compounds.
Jahić H; Liu CF; Thresher J; Livchak S; Wang H; Ehmann DE
Biochem Pharmacol; 2012 Sep; 84(5):654-60. PubMed ID: 22743594
[TBL] [Abstract][Full Text] [Related]
5. NAD+-dependent DNA ligase (Rv3014c) from Mycobacterium tuberculosis: novel structure-function relationship and identification of a specific inhibitor.
Srivastava SK; Dube D; Kukshal V; Jha AK; Hajela K; Ramachandran R
Proteins; 2007 Oct; 69(1):97-111. PubMed ID: 17557328
[TBL] [Abstract][Full Text] [Related]
6. Mycobacterium tuberculosis NAD+-dependent DNA ligase is selectively inhibited by glycosylamines compared with human DNA ligase I.
Srivastava SK; Dube D; Tewari N; Dwivedi N; Tripathi RP; Ramachandran R
Nucleic Acids Res; 2005; 33(22):7090-101. PubMed ID: 16361267
[TBL] [Abstract][Full Text] [Related]
7. Novel bacterial NAD+-dependent DNA ligase inhibitors with broad-spectrum activity and antibacterial efficacy in vivo.
Mills SD; Eakin AE; Buurman ET; Newman JV; Gao N; Huynh H; Johnson KD; Lahiri S; Shapiro AB; Walkup GK; Yang W; Stokes SS
Antimicrob Agents Chemother; 2011 Mar; 55(3):1088-96. PubMed ID: 21189350
[TBL] [Abstract][Full Text] [Related]
8. Discovery and Optimization of NAD+-Dependent DNA Ligase Inhibitors as Novel Antibacterial Compounds.
Bi F; Ma R; Ma S
Curr Pharm Des; 2017; 23(14):2117-2130. PubMed ID: 27784238
[TBL] [Abstract][Full Text] [Related]
9. Tricyclic dihydrobenzoxazepine and tetracyclic indole derivatives can specifically target bacterial DNA ligases and can distinguish them from human DNA ligase I.
Yadav N; Khanam T; Shukla A; Rai N; Hajela K; Ramachandran R
Org Biomol Chem; 2015 May; 13(19):5475-87. PubMed ID: 25875403
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of NAD(+) -dependent DNA ligase of mycobacteria as a potential target for antibiotics.
Korycka-Machala M; Rychta E; Brzostek A; Sayer HR; Rumijowska-Galewicz A; Bowater RP; Dziadek J
Antimicrob Agents Chemother; 2007 Aug; 51(8):2888-97. PubMed ID: 17548501
[TBL] [Abstract][Full Text] [Related]
11. Design, synthesis and biological evaluation of potent NAD+-dependent DNA ligase inhibitors as potential antibacterial agents. Part 2: 4-amino-pyrido[2,3-d]pyrimidin-5(8H)-ones.
Wang T; Duncan L; Gu W; O'Dowd H; Wei Y; Perola E; Parsons J; Gross CH; Moody CS; Arends SJ; Charifson PS
Bioorg Med Chem Lett; 2012 Jun; 22(11):3699-703. PubMed ID: 22560470
[TBL] [Abstract][Full Text] [Related]
12. Design, synthesis and biological evaluation of potent NAD+-dependent DNA ligase inhibitors as potential antibacterial agents. Part I: aminoalkoxypyrimidine carboxamides.
Gu W; Wang T; Maltais F; Ledford B; Kennedy J; Wei Y; Gross CH; Parsons J; Duncan L; Arends SJ; Moody C; Perola E; Green J; Charifson PS
Bioorg Med Chem Lett; 2012 Jun; 22(11):3693-8. PubMed ID: 22560473
[TBL] [Abstract][Full Text] [Related]
13. Cloning and functional characterization of an NAD(+)-dependent DNA ligase from Staphylococcus aureus.
Kaczmarek FS; Zaniewski RP; Gootz TD; Danley DE; Mansour MN; Griffor M; Kamath AV; Cronan M; Mueller J; Sun D; Martin PK; Benton B; McDowell L; Biek D; Schmid MB
J Bacteriol; 2001 May; 183(10):3016-24. PubMed ID: 11325928
[TBL] [Abstract][Full Text] [Related]
14. Identification of Novel Inhibitors of
Alomari A; Gowland R; Southwood C; Barrow J; Bentley Z; Calvin-Nelson J; Kaminski A; LeFevre M; Callaghan AJ; Vincent HA; Gowers DM
Molecules; 2021 Apr; 26(9):. PubMed ID: 33923034
[TBL] [Abstract][Full Text] [Related]
15. Discovery of bacterial NAD⁺-dependent DNA ligase inhibitors: improvements in clearance of adenosine series.
Stokes SS; Gowravaram M; Huynh H; Lu M; Mullen GB; Chen B; Albert R; O'Shea TJ; Rooney MT; Hu H; Newman JV; Mills SD
Bioorg Med Chem Lett; 2012 Jan; 22(1):85-9. PubMed ID: 22154350
[TBL] [Abstract][Full Text] [Related]
16. Specific and potent inhibition of NAD+-dependent DNA ligase by pyridochromanones.
Brötz-Oesterhelt H; Knezevic I; Bartel S; Lampe T; Warnecke-Eberz U; Ziegelbauer K; Häbich D; Labischinski H
J Biol Chem; 2003 Oct; 278(41):39435-42. PubMed ID: 12867414
[TBL] [Abstract][Full Text] [Related]
17. Toward the virtual screening of potential drugs in the homology modeled NAD+ dependent DNA ligase from Mycobacterium tuberculosis.
Singh V; Somvanshi P
Protein Pept Lett; 2010 Feb; 17(2):269-76. PubMed ID: 20214650
[TBL] [Abstract][Full Text] [Related]
18. Negishi cross-coupling enabled synthesis of novel NAD(+)-dependent DNA ligase inhibitors and SAR development.
Murphy-Benenato KE; Gingipalli L; Boriack-Sjodin PA; Martinez-Botella G; Carcanague D; Eyermann CJ; Gowravaram M; Harang J; Hale MR; Ioannidis G; Jahic H; Johnstone M; Kutschke A; Laganas VA; Loch JT; Miller MD; Oguto H; Patel SJ
Bioorg Med Chem Lett; 2015 Nov; 25(22):5172-7. PubMed ID: 26463129
[TBL] [Abstract][Full Text] [Related]
19. NAD(+)-dependent DNA ligase: a novel target waiting for the right inhibitor.
Dwivedi N; Dube D; Pandey J; Singh B; Kukshal V; Ramachandran R; Tripathi RP
Med Res Rev; 2008 Jul; 28(4):545-68. PubMed ID: 18080330
[TBL] [Abstract][Full Text] [Related]
20. Base-modified NAD and AMP derivatives and their activity against bacterial DNA ligases.
Pergolizzi G; Cominetti MM; Butt JN; Field RA; Bowater RP; Wagner GK
Org Biomol Chem; 2015 Jun; 13(22):6380-98. PubMed ID: 25974621
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
